Beraprost Sodium (Rapros) for Cats

Generic Name: Beraprost sodium.
Brand Names: Rapros is the brand name, developed by Toray Industries.
Available Formats: This medication is manufactured as a small, sustained release oral tablet. It is designed to be administered after a meal.

Plain English Goal: Beraprost sodium acts as a prostacyclin analog, meaning renal blood vessels are actively dilated. Oxygen delivery to strained kidney tissues is highly enhanced, while harmful inflammation and internal scarring, clinically known as fibrosis, are suppressed.
Target Symptoms and Lab Markers: This medication is targeted specifically for cats diagnosed with Stage 2 or Stage 3 chronic kidney disease. Success is tracked by veterinarians observing stabilized serum creatinine levels and prevented blood clots in the renal capillaries. Boosted appetite and overall hydration are also primary markers of success.
Response Window: Stabilized kidney function and delayed creatinine progression are generally observed over continuous, long term management, with clinical trials noting significant survival extensions.

Food Rules and Flavor: The oral tablet is strictly advised to be administered after feeding.
Aversion Guard: The medication must never be hidden in the primary bowl of renal diet. If the pill is detected, the staple food may be permanently associated with a negative experience and completely refused by the cat.
Missed Dose Protocol: If a dose is missed, the normal schedule should be resumed without doubling up.
Pregnancy Warning: This drug has not been tested for safety in pregnant felines and must strictly be avoided if a cat is or may be pregnant.

United States Approval: While this medication holds a massive market share and serves as a gold standard treatment for feline kidney disease in Japan, it is not currently FDA approved in the United States. Caretakers located outside of Asia frequently acquire it through specialized global pet healthcare importers.

Hemorrhage Risk: Because platelet aggregation is inhibited by this medication, it must never be administered to cats with active bleeding, a history of hemorrhage, or an abnormal platelet count.

Hydration Dependency: While overall hydration is often naturally boosted by the medication, a baseline level of adequate fluid balance is preferred to ensure optimal blood flow is maintained throughout the newly dilated renal vessels.

Mild Adjustments: Occasional mild vomiting or temporary loss of appetite is reported in under two percent of cases. Adverse events are considered generally very rare.
Emergency Red Flags: Immediate veterinary contact is required if any unexplained bruising, active bleeding, or profound lethargy is exhibited due to the known increased bleeding tendency.
Follow Up Lab Schedule: Routine kidney blood panels and strict platelet count monitoring should be expected to ensure the medication remains safe for the cat as the disease progresses.

Important Note: This content is provided for informational and educational purposes only to support caretakers. It is not a substitute for professional veterinary advice, diagnosis, or treatment. Always listen to your veterinarian for exact dosing instructions and schedules. Never start, stop, or adjust your cat's medication without directly consulting your primary veterinary care team.

Generic Name: Beraprost sodium.
Brand Names: Rapros is the brand name, developed by Toray Industries.
Available Formats: This medication is manufactured as a small, sustained release oral tablet. It is designed to be administered after a meal.

Plain English Goal: Beraprost sodium acts as a prostacyclin analog, meaning renal blood vessels are actively dilated. Oxygen delivery to strained kidney tissues is highly enhanced, while harmful inflammation and internal scarring, clinically known as fibrosis, are suppressed.
Target Symptoms and Lab Markers: This medication is targeted specifically for cats diagnosed with Stage 2 or Stage 3 chronic kidney disease. Success is tracked by veterinarians observing stabilized serum creatinine levels and prevented blood clots in the renal capillaries. Boosted appetite and overall hydration are also primary markers of success.
Response Window: Stabilized kidney function and delayed creatinine progression are generally observed over continuous, long term management, with clinical trials noting significant survival extensions.

Food Rules and Flavor: The oral tablet is strictly advised to be administered after feeding.
Aversion Guard: The medication must never be hidden in the primary bowl of renal diet. If the pill is detected, the staple food may be permanently associated with a negative experience and completely refused by the cat.
Missed Dose Protocol: If a dose is missed, the normal schedule should be resumed without doubling up.
Pregnancy Warning: This drug has not been tested for safety in pregnant felines and must strictly be avoided if a cat is or may be pregnant.

United States Approval: While this medication holds a massive market share and serves as a gold standard treatment for feline kidney disease in Japan, it is not currently FDA approved in the United States. Caretakers located outside of Asia frequently acquire it through specialized global pet healthcare importers.

Hemorrhage Risk: Because platelet aggregation is inhibited by this medication, it must never be administered to cats with active bleeding, a history of hemorrhage, or an abnormal platelet count.

Hydration Dependency: While overall hydration is often naturally boosted by the medication, a baseline level of adequate fluid balance is preferred to ensure optimal blood flow is maintained throughout the newly dilated renal vessels.

Mild Adjustments: Occasional mild vomiting or temporary loss of appetite is reported in under two percent of cases. Adverse events are considered generally very rare.
Emergency Red Flags: Immediate veterinary contact is required if any unexplained bruising, active bleeding, or profound lethargy is exhibited due to the known increased bleeding tendency.
Follow Up Lab Schedule: Routine kidney blood panels and strict platelet count monitoring should be expected to ensure the medication remains safe for the cat as the disease progresses.

Important Note: This content is provided for informational and educational purposes only to support caretakers. It is not a substitute for professional veterinary advice, diagnosis, or treatment. Always listen to your veterinarian for exact dosing instructions and schedules. Never start, stop, or adjust your cat's medication without directly consulting your primary veterinary care team.